Présentations

Bridging health technology assessment with multicriteria decision analyses: field testing of the EVIDEM framework to support coverage decision for tramadol by a public health plan in Canada
Tony M, Goetghebeur MG, Wagner M, Khoury H, Rindress D, Oh P
CADTH 2010 Symposium, 18-20 April, 2010, Halifax, NS, Canada

Multicriteria decision analyses for healthcare decisionmaking: feedback from the field on the value of the EVIDEM framework in Canadian and South African settings
Goetghebeur MG, Miot J, Tony M, Wagner M, Khoury H, Rindress D, Oh P
The International Society for Priorities in Health Care, 23-25 April, 2010, Boston, MA, USA

Burden of rotavirus gastroenteritis in the Middle Eastern pediatric population
Ogilvie I, Khoury H, El-Khoury A, Duan Y, Goetghebeur M
European Society for Pediatric Infectious Diseases, 4-8 May, 2010, Nice, France

Multicriteria Decision Analysis (MCDA) for drug coverage decision by a Public Health Plan: case study of tramadol for chronic non-cancer pain (CNCP) in Canada
Tony M, Goetghebeur MM, Wagner M, Khoury H, Rindress D, Oh P
The International Society of Pharmacoeconomics and Outcomes Research, May 15-19, 2010, Altanta, GA, USA

Bridging health technology assessment with Multicriteria Decision Analysis (MCDA) and an ethical framework for complex decisions: Case study for growth hormone for Turner Syndrome
Goetghebeur MM, Wagner M, Khoury H, Rindress D, Grégoire JP, Deal C
ISPOR 12th Annual European Congress, 24-27 October 2009, Paris, France

Field testing of a Multicriteria Decision Analyses (MCDA) framework for coverage of a diagnostic test for cervical cancer in South Africa
Miot J, Wagner M, Khoury H, Anderson AN, Rindress D, Goetghebeur MM
ISPOR 12th Annual European Congress, 24-27 October 2009, Paris, France

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions
Ogilvie I, El Khoury A, Cui A, Dasbach E, Grabenstein JD, Goetghebeur M
ISPOR 14^th Annual Meeting, 16-20 May, 2009, Orlando, Florida, USA

Growth hormone for treating Turner syndrome in Canada: structuring evidence into the EVIDEM multicriteria decision analysis framework to support decisionmaking
Goetghebeur MM, Khoury H, Wagner M, Rindress D, Grégoire JP, Deal C
CAPT 2009 Annual Conference, 19-21 April, 2009, Montreal, Quebec, Canada

Field application of the EVIDEM multicriteria decision framework to support coverage decisions for a screening test
Goetghebeur MM, Miot J, Wagner W, A Nixon Anderson, Khoury H, Rindress D
CADTH 20^th Anniversary 2009 Symposium, 5-7 April 2009, Ottawa, Ontario, Canada

Sub-optimal oral anticoagulant treatment in patients with atrial fibrillation and the effect of study setting on clinical event rates: a systematic review
Ogilvie IM, Newton N, Welner SA, Lip GYH
American College of Cardiology and i2 Summit 58th Annual Scientific Session, 29-31 March 2009, Orlando, Florida, USA

Evidence and Value: Impact on DEcisionMaking (EVIDEM)—a practical framework applying mutlicriteria decision analysis (MCDA) to support healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
CADTH 2008 Invitational Symposium, 28-29 April 2008, Edmonton, Alberta, Canada

Cost-effectiveness of atorvastatin 10 mg daily in the primary prevention of major cardiovascular events in patients with type 2 diabetes in Canada
Khoury H, Wagner M, Merikle E, Johnson SJ, Roberts C
9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 30 Apr–2 May 2008, Baltimore, Maryland, USA

Evidence and Value: Impact on DEcisionMaking—the EVIDEM framework and potential applications
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
ISPOR 13th Annual International Meeting, 3-7 May 2008, Toronto, Ontario, Canada

Transparent and quantifiable approaches to healthcare decisionmaking: challenges and opportunities for Multi Criteria Decision Analysis (MCDA)
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
ISPOR 13th Annual International Meeting, 3-7 May 2008, Toronto, Ontario, Canada

Costs related to adverse events in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors in Canada
Newton N, Goetghebeur MM, El Ouagari K
ISPOR 13th Annual International Meeting, 3-7 May 2008,Toronto, Ontario, Canada

Concordance with compression therapy in the treatment of venous leg ulcers
Machado F, Kommala D, Dourdin N, Welner S, Choe Y
European Wound Management Association (EWMA) Conference, 14-16 May 2008, Lisbon, Portugal.

Evidence and Value: Impact on DEcisionMaking (EVIDEM)—applying Multi-Criteria Decision Analysis (MCDA) to support healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
5th Annual Meeting HTAi 2008, 6-9 July 2008, Montreal, Quebec, Canada

Multi Criteria Decision Analysis (MCDA) in healthcare decisionmaking: towards transparent and quantifiable approaches
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
5th Annual Meeting HTAi 2008,6-9 July 2008, Montreal, Quebec, Canada

How do Evidence and Value Impact DEcisionMaking? EVIDEM – a practical framework applying Multi-Criteria Decision Analysis (MCDA) to structure and facilitate healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
9th World Conference on Clinical Pharmacology and Therapeutics Annual Meeting, 27 July-1 Aug, 2008, Quebec City, Canada

Cost-effectiveness of 80 mg versus 10 mg atorvastatin in Canada based on results of the TNT study
Wagner M, Merikle E, Goetghebeur M, Pandya A, Chu P, Taylor DCA
4th Canadian Therapeutics Congress, 27-30 May 2007, Halifax, NS, Canada

Economic evaluation of intensive atorvastatin compared to standard simvastatin treatment in Canada based on the IDEAL trial
Wagner M, Lindgren P, Merikle E , Goetghebeur M, Jönsson B & the IDEAL Steering Committee Investigators.
4th Canadian Therapeutics Congress, 27-30 May 2007, Halifax, NS, Canada

Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences
Goetghebeur M, Landry P, Han D, Vicente C
3rd annual conference of the Canadian Therapeutics Congress, 10-13 May 2006, Toronto, Ontario. Canada

Real world issues facing outcomes data collection and analysis – case studies
Rindress D
Disease Management Leadership Forum, 16 October 2005, San Diego, California, USA

Trends in pharmaceutical spending growth in the United States, 1998-2002
Roberts WM, Rindress D
ISPOR 10th Annual International Meeting, 15-18 May 2005, Washington, DC, USA

Economic impact of reduced incidence of diabetes in patients with left ventricular dysfunction treated with enalapril
McLachlin DT, Rindress D, Desjardins B, Tardif J-C
2005 Canadian Association for Population Therapeutics Conference, 17-19 April 2005, Vancouver, BC, Canada

Economic impact of reduced incidence of atrial fibrillation in patients with left ventricular dysfunction treated with enalapril
Wagner M, McLachlin DT, Rindress D, Desjardins B, Ducharme A, Tardif J-C
54th Annual Scientific Session of the American College of Cardiology, 6-9 March 2005, Orlando, FL, USA

Global Economic Dossiers: speaking with one voice globally
Rindress D
Drug Information Association workshop on Medical/Technical Writing and Document Preparation for the Pharmaceutical Industry, October 2002, Baltimore, MD, USA

Application of health economics in the Canadian pharmaceutical industry
Hirji Z, Rindress DE, Welner SA
ISPOR 6th Annual International Meeting , 20-23 May 2001, Washington, DC, USA

Begin with the end in mind: issues in planning pharmacoeconomic research for more effective communication
Rindress D
ISPOR 4th Annual International Meeting 23-26 May 1999, Crystal City, VA, USA, Value in Health 1999;2(3):227

Effectively reporting pharmacoeconomic data: clarity and content
Rindress D, Welner S, Goetghebeur M
2nd Annual Meeting of the Association for Pharmacoeconomics and Outcomes Research, 23-26 April 1997,
Philadelphia, PA, USA

Meeting the emerging standards for reporting pharmacoeconomic data
Rindress D, Welner S, Goetghebeur M
Drug Information Association workshop on Medical/Technical Writing and Document Preparation for the Pharmaceutical Industry, 3-4 April 1997, Baltimore, MD, USA

Cost effectiveness of paclitaxel in advanced ovarian cancer
Rivière M, Rindress D, Souêtre E
1st Annual Meeting of the Association for Pharmacoeconomics and Outcomes Research, 12-15 May 1996, Philadelphia, PA, USA, Clinical Therapeutics 1996;18(Suppl.A):24.

Haut de page